Robotics and AI in Drug Manufacturing: May Unlock Efficiency Gains, Long-Term Value
AINewsWire Editorial Coverage: Pharmaceutical manufacturing is entering a period of structural transformation as regulators impose increasingly stringent expectations around contamination control, data integrity and operational traceability. The European Union’s updated GMP Annex 1 guidance places strong emphasis on minimizing human involvement and implementing comprehensive contamination control strategies, requiring manufacturers to evaluate and mitigate risks across personnel, processes and environments. It also encourages the use of barrier systems and automation technologies, reflecting the widely accepted understanding that human operators represent a primary contamination source in sterile production settings. In addition, findings from inspections conducted by the U.S. Food and Drug Administration…